Columbia Sportswear vs Carters
COLM and CRI side by side, both in apparel and other finished products made from fabrics and similar materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How COLM and CRI compare
Columbia Sportswear is the larger company, worth 2.9 times as much as Carters ($3.7B against $1.3B).
On earnings, Carters is cheaper: it trades at 5.7× trailing earnings, against 15.8× for Columbia Sportswear.
Carters grew revenue faster over the last twelve months (5.0% versus 0.07% for Columbia Sportswear).
Carters keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with 7.0% at Columbia Sportswear.
Both pay dividends: Columbia Sportswear yields 1.7% and Carters 2.9%.
Carters scores higher on the StockData Score (21 against 19 for Columbia Sportswear), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | COLM | CRI |
|---|---|---|
| Size and price | ||
| Market cap | $3.7B | $1.3B |
| Share price | $72.19 | $34.60 |
| Change, 1 year | 41.4% | 6.2% |
| Change, 5 years | −30.1% | −67.6% |
| Beta (5Y) | 0.74 | 0.93 |
| Employees | 9,620 | 15K |
| StockData Score | ||
| Total score | 19 | 21 (better) |
| Valuation score | 4 | 6 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 4 | 5 (better) |
| Health score | 6 (better) | 4 |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 15.8× | 5.7× (better) |
| P/S | 1.1× | 0.4× (better) |
| P/B | 2.3× | 1.2× (better) |
| EV/EBITDA | 9.8× | 3.7× (better) |
| P/FCF | 13.4× | 4.0× (better) |
| FCF yield | 7.5% | 25.2% (better) |
| Fair value | $82.79 | $84.85 |
| Margin of safety | 12.8% | 59.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 0.07% | 5.0% (better) |
| Revenue growth, 5Y average | 6.3% (better) | −0.85% |
| Net income growth (TTM) | 27.9% | 147% (better) |
| EPS growth (TTM) | 37.8% | 145% (better) |
| EPS growth, 5Y average | 14.9% (better) | 0.24% |
| Profitability | ||
| Gross margin | 52.1% (better) | 49.1% |
| Operating margin | 8.7% | 10.4% (better) |
| Net margin | 7.0% | 7.4% (better) |
| FCF margin | 8.0% | 10.7% (better) |
| Return on equity | 14.5% | 22.9% (better) |
| Return on invested capital | 16.0% | 21.3% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.54 (better) |
| Net debt / EBITDA | – | 0.12 |
| Interest coverage | – | 6.7× |
| Current ratio | 2.60 | 2.78 (better) |
| Altman Z-score | 4.83 (better) | 2.93 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.7% | 2.9% (better) |
| Payout ratio | 26.1% | 16.6% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 35.8% (better) | 20.9% |
| Buyback yield | 6.2% | – |
| Shareholder yield | 7.9% (better) | 2.9% |
| Ownership | ||
| Held by institutions | 51.1% | 107% |
| Held by insiders | 52.7% | 3.6% |
| Insider net buying, 12 months | −$3.0M | – |
| Short interest, % of float | 18.9% | 17.6% |
Go deeper
- COLM stock overview
- COLM income statement
- COLM valuation and score
- CRI stock overview
- CRI income statement
- CRI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.